🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Capecitabine

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer NCT06105684Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Capecitabine Pill CtDNA-guided Maintenance Therapy in Pancreatic Cancer NCT07054879n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC NCT07331428Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: MRG003, Tislelizumab, Capecitabine Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer. NCT06771609Phase 22 sites📍 Beijing📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Adebrelimab + VEX metronomic chemotherapy + radiotherapy, Adebrelimab + VEX metronomic chemotherapy Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC NCT06533384Phase 31 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Ca… Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks NCT05212454Phase 31 site📍 Hanzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Capecitabine Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response NCT06239727Phase 326 sites📍 Fuzhou📍 Xiamen📍 Dongguan Sun Yat-sen University · Tests: PD-1 blocking antibody, Gemcitabine, Cisplatin (80 mg/m2), Reduced-dose Intensity-modulated radiotherapy, Conventional-… Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer NCT06405139Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors NCT04165772Phase 210 sites📍 Hartford📍 Miami📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: TSR-042 or Dostarlimab, capecitabine or 5-FU, Intensity Modulated Radiation Therapy (IMRT) A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases NCT06764940Phase 212 sites📍 Duarte📍 Los Angeles📍 San Diego Biostar Pharma, Inc. · Tests: Utidelone, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, Utidelone in combina… Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery NCT05973864Phase 220 sites📍 Amiens📍 Avignon📍 Bayonne UNICANCER · Tests: Pembrolizumab injection, Capecitabine tablets, Local radiotherapy XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma NCT05494060Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Anlotinib hydrochloride capsule, Penpulimab Injection, XELOX A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma NCT07768189Phase 3111 sites📍 Huntsville📍 Tucson📍 Duarte Corbus Pharmaceuticals Inc. · Tests: CRB-701, capcitabine, Cetuximab (EGFR inhibitor), Docetaxel Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC NCT06023758Phase 21 site📍 Beijing Peking University · Tests: KN026, KN046, XELOX Metronomic Capecitabine in Stage III Gastric Cancer NCT06313567Phase 31 site📍 Shanghai Fudan University · Tests: Metronomic capecitabine group, Observation Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer NCT06282445Phase 21 site📍 Jinhua The Fourth Affiliated Hospital of Zhejiang University Schoo… · Tests: Adebrelimab, Oxaliplatin, Capecitabine, Bevacizumab A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer NCT05093907Phase 1, Phase 21 site📍 Seoul BeyondBio Inc. · Tests: BEY1107, Capecitabine Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling NCT04965064Phase 21 site📍 Rochester University of Rochester · Tests: Capecitabine and Neratinib. Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial NCT06850090Phase 31 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: TAS-102, Capecitabine Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment NCT07467330Phase 31 site📍 Fuzhou Fujian Cancer Hospital · Tests: dalpiciclib + capecitabine + endocrine therapy, dalpiciclib + endocrine therapy Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy NCT06992336Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Apatinib, Camrelizumab, Capecitabine Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer. NCT06888843Phase 21 site📍 Nizhny Novgorod Nizhny Novgorod Regional Clinical Oncology Center · Tests: Capecitabine, Oxaliplatin Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) NCT05177133Phase 28 sites📍 Amsterdam📍 Amsterdam📍 Eindhoven Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Capecitabine, Oxaliplatin, Retifanlimab Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer NCT06532617Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Cadonilimab+S-1or Capecitabine Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer NCT05861271Phase 21 site📍 Shanghai Fudan University · Tests: Capecitabine，Pyrotinib A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer NCT06776770Phase 1, Phase 21 site📍 Shenzhen Cancer Hospital Chinese Academy of Medical Science, Shenzhe… · Tests: Adebrelimab Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer NCT05136326Phase 21 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: External-beam radiation, Capecitabine, Temozolomide Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer. NCT07407465Phase 228 sites📍 Lyon📍 Marseille📍 Paris Gruppo Oncologico del Nord-Ovest · Tests: Trastuzumab-Deruxtecan (T-DXd), Capecitabine, Bevacizumab Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC NCT06555133Phase 21 site📍 Providence Brown University · Tests: yttrium-90 radioembolization
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy